Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.
Funakoshi Y, Fujiwara Y, Kiyota N, Mukohara T, Shimada T, Toyoda M, Imamura Y, Chayahara N, Tomioka H, Umezu M, Otsuki N, Nibu K, Minami H.
Funakoshi Y, et al. Among authors: chayahara n.
Cancer Chemother Pharmacol. 2016 Feb;77(2):281-8. doi: 10.1007/s00280-016-2966-1. Epub 2016 Jan 20.
Cancer Chemother Pharmacol. 2016.
PMID: 26791871
Free PMC article.